Lidija Kandolf-Sekulovic, MD, PhD of the Military Medical Academy, Belgrade, Serbia gives a press brief on the results of the…
Browsing: Acute Lymphoblastic Leukemia
Andrés Cervantes, MD, PhD of University of Valencia, Valencia, Spain introduces the press conference and the presidential symposia at ESMO…
Ulrik Lassen, MD, PhD of Copenhagen University Hospital, Copenhagen, Denmark talks about cancer in Denmark and the role of ESMO…
Solange Peters, MD, PhD of Lausanne University Hospital, Lausanne, Switzerland kicks-off the first press conference at ESMO 2016. This year’s…
Federico Caligris-Cappio, MD of Università Vita-Salute San Raffaele, Milan, Italy, talks about the key questions to be discussed at International…
Federico Caligris-Cappio, MD of Università Vita-Salute San Raffaele, Milan, Italy, talks about the International Workshop on Chronic Lymphocytic Leukemia (iwCLL),…
Carlo Croce, MD of The Ohio State University, Columbus, OH provides an overview of microRNA and ROR1 as part of…
“Stephan Stilgenbauer, MD, PhD of Ulm University, Ulm, Germany talks about the International Workshop on Chronic Lymphocytic Leukemia (iwCLL), which…
Nicholas Chiorazzi, MD from The Feinstein Institute for Medical Research, Manhasset, NY provides an overview of the program of the…
Federico Caligaris-Cappio, MD of Università Vita-Salute San Raffaele, Milan, Italy, disucsses how to removal of macrophages can stop progression of…
Carsten Niemann, MD, PhD of Rigshospitalet, Copenhagen, Denmark dicusses the development of new advanced methods to identify chronic lymphocytic leukemia…
Carlo Croce, MD of The Ohio State University, Columbus, OH provides an overview of his research on the epigenetics and…
Arnon Kater, MD, PhD of the Academic Medical Center, Amsterdam, Netherlands talks about the problem of resistance to new drugs…
How the Cleveland Clinic uses Tomosynthesis Mammogram with Dr. Leah Sieck, MD Diagnostic Radiologist
Dr. Chirag Shah, MD Radiation Oncologist at Cleveland Clinic discusses several new radiation methods he uses for breast cancer patients.
Dr. Charis Eng, MD Chair and Founding Director of Cleveland Clinic Genomic Medicine Institute outlines the guidelines that the Cleveland…
Leah Sieck, MD Diagnostic Radiologist and Jame Abraham, MD of Cleveland Clinic discuss the guidelines that they use in breast…
Topics: How do you get all team members to work together? How does this collaboration improve patient care and value…
In this Ask the Expert segment, Dr. Larry Anderson, Jr. of University of Texas Southwest Medical Center answers a question…
Clemens Schmitt, MD of the Max Delbruck Center for Molecular Medicine, Berlin, Germany discusses the clinical implications of targed therapies…
“Laurie Sehn, MD of British Columbia Cancer Agency, Vancouver, Canada discusses the standard of care for patients with diffuse large…
“Clemens Schmitt, MD of the Max Delbruck Center for Molecular Medicine, Berlin, Germany discusses the ongoing debate about the two…
Andrew Davies, MRCP, PhD of University Hospital of Southampton, Southampton, UK talks about upcoming trials in diffuse large B-cell lymphoma…
“Laurie Sehn, MD of British Columbia Cancer Agency, Vancouver, Canada discusses the use of PET scan to identify diffuse large…
Clemens Schmitt, MD of the Max Delbruck Center for Molecular Medicine, Berlin, Germany discusses the potential to use targeted therapy…
“Bjoern Chapuy, MD, PhD of Dana-Farber Cancer Institute, Boston, MA gives an overview of his talk on targeted molecular signatures…
Andrew Davies, MRCP, PhD of University Hospital of Southampton, Southampton, UK discusses his highlights from the 2016 International Workshop on…
Jeffrey Weber, MD, PhD from the NYU Langone Medical Center, New York, NY discusses his talk on novel combination therapies…
Larisa Geskin, MD of Columbia University Medical Center, New York, NY summarizes her views on the developments and upcoming meetings…
Victoria Sherwood , PhD of the University of Dundee, Dundee, UK, talks about the next steps for the research into…
Robert Andtbacka, MD, CM of the Huntsman Cancer Institute, Salt Lake City, UT talks about neoadjuvant studies at the 2016…
“Peter Petzelbauer, MD, of the Medical University of Vienna, Vienna, Austria, discusses the differences in number of clinical trials for…
Robert Knobler, MD of the Medical University of Vienna, Vienna, Austria talks about the future of extracorporeal photopheresis for the…
Robert Andtbacka, MD, CM of the Huntsman Cancer Institute, Salt Lake City, UT discusses the use of oncolytic viruses at…
Jürgen Becker, MD, PhD from the University Hospital Essen, Essen, Germany speaks to us on the importance of stratified treatments…
Jeffrey Weber, MD, PhD from the NYU Langone Medical Center, New York, NY discusses what he hopes to achieve with…
Maria Concetta Fargnoli, MD, form the University of LAquila, LAquila, Italy discusses the developments made in melanoma genetics owing to…
“Peter Petzelbauer, MD, of the Medical University of Vienna, Vienna, Austria, discusses the next steps for his research and clinical…
Paul Lorigan, MB, BCH, BAO, BA, FRCP of the University of Manchester, Manchester, UK, discusses the problem of chemotherapy for…
“Peter Petzelbauer, MD, of the Medical University of Vienna, Vienna, Austria, discusses the role of lymphangiogenesis in melanoma at the…
Paolo Ascierto, MD of the National Tumor Institute Fondazione G. Pascale, Naples, Italy discusses drug combinations in melanoma as part…
Maria Concetta Fargnoli, MD, form the University of LAquila, LAquila, Italy discusses genetic screening in melanoma at the 2016 World…
Martin Mihm, Jr., MD of Brigham and Women’s Hospital, Boston, MA, discusses the importance of therapeutic checkpoint blockers at the…
Larisa Geskin, MD of Columbia University Medical Center, New York, NY discusses the future of the treatment of cutaneous T-cell…
Jürgen Becker, MD, PhD from the University Hospital Essen, Essen, Germany discusses new innovative treatment options for Merkel cell carcinoma…
Jeffrey Weber, MD, PhD of the NYU Langone Medical Center, New York, NY discusses combination therapy options for melanoma at…
Isaac Brownell, MD, PhD of the National Cancer Institute, Bethesda, MD discusses the virus associated with Merkel cell carcinoma and…
Brigitte Dréno, MD, PhD from the University Hospital of Nantes, Nantes, France discusses current and future clinical trials in melanoma…
Marc Peeters, MD, PhD, of Antwerp University Hospital, Edegem, Belgium, gives a summary of some of the data presented on…
Dr Mansoor Mirza, chief oncologist at Copenhagen University Hospital, Denmark and medical director of the Nordic Society of Gynaecological Oncology…